CV death or myocardial infarction
1 paper1 finding
- Humans1
Associations
1PROSPER
upin humans1
1 study
PROSPER
upin humans1
PROSPER raises the risk of CV death or myocardial infarction in humans (adjHR 1.62, 95% CI 1.35-1.92).
“those in the highest quintile had a significantly elevated risk of CV death or MI (adjHR 1.62, 95% CI 1.35-1.92”
Humanshighest vs lowest quintile, adjusting for age, sex, race, ethnicity, diabetes, and BMI13.6 yearsn = 50,689
A PROtein Signature of PlatelEt Reactivity (PROSPER) Associated with Cardiovascular Events
AHA Scientific Sessions 2025 abstract3 Nov 2025
Latest
2 in 12 monthsAHA Scientific Sessions 2025 Abstract
A PROtein Signature of PlatelEt Reactivity (PROSPER) Associated with Cardiovascular Events
Cohort study of 50,689 peopleCardiovascular disease
AHA Scientific Sessions 2025 Abstract
Effects on major adverse cardiovascular events in persons treated with sotagliflozin: Prespecified pooled analyses of the Phase 3 type 2 diabetes program
Meta-analysis of randomised trialsType 2 diabetes